Ataluren treatment of patients with nonsense mutation dystrophinopathy

ABSTRACT Introduction : Dystrophinopathy is a rare, severe muscle disorder, and nonsense mutations are found in 13% of cases. Ataluren was developed to enable ribosomal readthrough of premature stop codons in nonsense mutation (nm) genetic disorders. Methods : Randomized, double‐blind, placebo‐contr... View More